Medical Extended Reality Conference

Advancements in Technology, Applications, and Regulatory Science

October 24-25, 2023 | Bethesda, MD


Join FDA, Industry leaders and MDIC in this exciting two-day regulatory science conference! #MXR2023 will bring together leaders in Augmented/Virtual/Mixed reality (AR/VR/MR) who are focusing on healthcare applications. Learn about technological advances, current medical applications, drivers of innovation and adoption, and recent regulatory advances in the field of medical extended reality (MXR).

Goals of #MXR2023

  • An update to FDA 2020 Workshop on MXR: What has changed? Where are we? Progress? What are the big challenges that we face today? How to address the challenges? 
  • Discuss challenges to implementation: Innovative MXR devices are not transitioning effectively from the development stage to clinical use and widespread adoption. 
  • Provide a neutral space for stakeholder representatives from industry and regulators in AR/VR/MR.
  • Identify a roadmap to accelerate MXR innovation and adoption by clarifying evaluation challenges and solutions.
  • Develop an ecosystem to bring disparate components together, facilitate synergies between stakeholders across the total product lifecycle. 

Agenda at a Glance

Click + to expand to see the session description and speaker info.

Day 1 (Tuesday, October 24, 2023)


  • Jennifer Waters
  • Jithesh Veetil


  • Andy Fish


  • Marc Griswold, Case Western Reserve Univ (invited)
  • Peter Yang, De Novo Program Lead, Team Lead, FDA/CDRH/OPEQ/ORP/DRP1/TRP1A, FDA (invited)
  • Chris Harner, OHT6 Medical Officer FDA (invited)

What progress has been made since the FDA Public Workshop on MXR in 2020? What are the big challenges that we face today and how we can work together to resolve them.


  • Laurence Coyne, FDA
  • Chris Harner, FDA
  • Michel Janda, FDA  
  • Lisa Kinnard, FDA  
  • Alex Beylin, FDA  
  • Ian Broverman, FDA  


  • Lucas Fernandez, Reality Labs
  • Grace Hwang, Microsoft 


  • Patrick Shironoshita 

Hardware manufacturers share clinical uses of XR and the evolving ecosystem.  


  • Jennifer Silva, Director, Pediatric Electrophysiology, Professor, Pediatrics and Biomedical Engineering, Washington University SOM
  • Dr. Charles Martin, Vascular and Interventional Radiologist Cleveland Clinic


  • Vangelis Lympouridis    

MXR industry discusses recent technological developments, product improvements, standardization and regulatory efforts and remaining challenges.


  • Michael Uohara, CMO Microsoft

MXR is a powerful technology that can enhance healthcare. Michael Uohara will present some of the use-cases for MXR in healthcare, such as training, patient engagement, collaboration, and visualization. He will also discuss the opportunities to scale MXR to address real healthcare challenges, such as accessibility, affordability, and quality. He will share some of the best practices and lessons learned from implementing MXR solutions in different healthcare settings. He will also highlight some of the future trends and directions for MXR in healthcare, such as personalization, integration, and innovation. 


  • Brad Pua, Associate Professor of Radiology in Cardiothoracic Surgery (Cornell)
  • Keith Horton, Interventional Radiologist (Georgetown)
  • Brad Wood, Chief of IR (NIH)
  • Amitabh Varshney , University of Maryland


  • Sara Murthi, University of Maryland  

Discover pioneering research, design, and innovation in Medical XR through visionary projects and groundbreaking advancements in clinical use.


  • Mina Fahim, MediView
  • Michael Southworth, SentiAR
  • Vangelis Lympouridis, Enosis CEO
  • Karly Yoder, GE Healthcare (invited)
  • Phil Radcliff, GE Healthcare (invited)


  • Jonathan Wakim 

The journey of existing MXR devices and best practices in regulatory compliance, user-centered design, clinical trials, and commercialization.


  • Annie Saha, FDA/DHCoE 


  • Leonardo Angelone

National Institute on Drug Abuse (NIDA) activities with start-up medical device companies using virtual reality for pain management. 


  • Patrick Littlefield, Deloitte (invited)
  • Oliver Fleig, BrainLab 
  • Lars Riedemann, Heidelberg University Hospital 
  • Doug Billing, Deloitte (invited)
  • Kyle Maddock, Apptek 


  • Jack Xu  

Day 2 (Wednesday, October 25, 2023)


  • Jennifer R. Waters, Project Manager (MDIC)
  • Jithesh Veetil, Senior Director, (MDIC)


  • Ryan Beams, FDA
  • Chumin Zhao, FDA Staff Fellow/OSEL
  • Ed Margerrsion, FDA/OSEL  (invited)

FDA/Office of Science and Engineering Laboratories (OSEL) on Advances in MXR Regulatory Science, including current research, regulatory science tools, and future challenges. 


  • Luana Colloca, University of Maryland
  • Alex Cadotte Regulatory, MCRA (invited)
  • Gretchen Nelson Clinical, MCRA (invited)
  • Susan Persky, FDA

Challenges and innovative approaches for clinical trial design in Medical XR. Discuss strategies for rigorous evaluation, patient engagement and regulatory compliance.


  • John Penczek – Hardware/Standards, NIST
  • Glenn Raudins, MediView
  • Jeff Bail, Vicarious Surgical 

Landscape of current testing methodology ensuring performance, image quality, safety, and user experience in MXR and identification of remaining challenges.  


  • Dr. Ali Dhanaliwala, M.D., PhD, University of Pennsylvania
  • Mary Beth Privitera, University of Cincinnati
  • John Rice, Eclectic Behavioral Science, Modeling and Simulation   


  • Marc Egeth, Medical Device Human Factors  

Discuss Human Factors and Human-centered design in MXR. Explore usability, safety, user experience considerations, and risk mitigation strategies in product development. 


Brennan Spiegel, Cedar-Sinai Hospital

The field of MXR is rapidly expanding, with exponential growth in peer-reviewed papers over the past decade. However, there remain opportunities to enhance the rigor of MXR research. In this talk, we will review a framework for how to systematically develop and assess MXR applications in partnership with multidisciplinary teams and end-users. We will discuss examples where patient feedback led to significant changes in software, review trial methodologies for examining the efficacy of MXR therapeutics and examine approaches for human-centered design in MXR. We will end with recent examples using this approach to develop and test applications that combine VR and AI to support mental health, alleviate gastrointestinal symptoms, and help manage addiction. 


  • Kunal Chaudhary, Managing Scientist at Exponent
  • Shweta Daga, Director of Regulatory Affairs at Align Technology
  • Rishi Reddy, University of Michigan
  • Danny Goel, PrecisionOS 

The transformative potential of MXR in healthcare training and education through simulation and specialized instructional design.  


  • Anne Bailey, Director, Clinical Tech Innovation at U.S. Department of Veterans Affairs
  • Caitlin Rawlins, Veteran Affairs 
  • Mark Zhang, AMXRA
  • Joe Morgan, Waya Health 

MXR deployment, scalability, and operationalization successes and challenges in a clinical setting.  


  • Liesl Oldstone, Vice President, Health Economics and Market Access at AppliedVR
  • Emily Holland, Senior Vice President at Capitol Hill Consulting
  •  Chris Davis  Senior Vice President at Capitol Hill Consulting


  • Heather Benz

Technology, systems integration, healthcare economics, payment and reimbursement as drivers for adoption.

Registration Rates

CategoryEarly bird PricingRegular Pricing
Industry (MDIC Non-Member)$850$1,000
Industry (MDIC Member)$750$900
Student/Post-Doctoral Researcher$400$500

pricing ends September 8!

Who Should Attend #MXR2023

Medical device industry professionals 

  • Quality & Regulatory (QA/RA) professionals, including those who are responsible for regulatory and economic strategy or implementation of AR/VR/MR
  • Technology experts that are making advances in the MXR space through new technology or use cases 

Platform developers  

Regulatory Affairs and policy professionals from industry and government  

  • FDA Review and research teams related to AR/VR/MR technology 
  • Government and private Payors as well as Reimbursement subject matter experts  
  • Government professionals that have direct input to standards and policies related to MXR 

Healthcare professionals 

  • Early adopters of AR/VR/MR technology in their practice 
  • Those who have used AR/VR/MR but are curious to learn more 

Patients and Patient Advocates 

Conference Venue and Hotel Accommodations

The Medical Extended Reality (MXR): Advancements in Technology, Applications and Regulatory Science Conference will be held in person at Bethesda North Marriott Hotel & Conference Center, conveniently located at 5701 Marinelli Road, Bethesda, Maryland 20875.

Bethesda North Marriott Hotel & Conference Center is centrally located in Bethesda, Maryland, and is within a short distance from Downtown Bethesda where you can enjoy boutique shopping, award-winning dining, and entertainment. Click the link above to reserve a room at our special discounted rate of $278/night

How to Get There

Air Travel

  • Ronald Regan Washington National Airport (18 miles from location)
  • Dulles International Airport (25 miles from location)
  • Baltimore/Washington International Thurgood Marshall Airport (35 miles from property)

Land Travel

  • Greyhound Bus Station – Union Station
  • Amtrak – Union Station
  • North Bethesda Metro Station